CRO / CDMO Optimization
Contract research and manufacturing organizations face constant pressure to improve efficiency, reduce timelines, and maintain quality across an increasingly complex portfolio of client engagements. Dr. Kurr's expertise in global operating model design - including shared services, offshoring, and process standardization - applies directly to CRO/CDMO operations. His approach focuses on identifying which processes can be standardized and centralized, which require local flexibility, and how to build governance structures that balance efficiency with client-specific requirements. The result is an operating model that scales without sacrificing quality or responsiveness.
Contract Commercialization (CCO)
Contract commercial organizations provide outsourced commercial capabilities - from sales force deployment to medical affairs support to content production. Dr. Kurr built exactly this type of organization inside Boehringer Ingelheim, giving him a unique insider perspective on what makes contract commercial services successful. He understands both sides: what the client organization needs (flexibility, quality, cost predictability) and what the service organization needs (standardization, talent development, technology infrastructure). This dual perspective makes his advisory work with CCOs and CSOs uniquely practical and grounded.
Service Delivery Transformation
Service delivery in life sciences is being transformed by technology - AI-enabled workflows, automated quality checks, digital collaboration platforms, and data-driven performance management. But technology adoption in service organizations requires careful change management: client-facing teams resist changes that might disrupt established relationships, and quality standards in regulated environments create additional constraints. Dr. Kurr's experience managing precisely this type of transformation at Boehringer Ingelheim - introducing AI and digital tools into regulated service delivery workflows - provides the practical blueprint for life sciences service organizations looking to modernize.
Global Capability Build-Out
Life sciences service companies expanding globally face the challenge of replicating service quality across different geographies while adapting to local regulatory requirements, talent markets, and client expectations. Dr. Kurr achieved full geographical scale at Boehringer Ingelheim within four years, starting with the Singapore/ASKAN region and expanding to cover all markets worldwide. His stage-gate transition planning methodology - piloting in select geographies, stabilizing, and then scaling - de-risks global expansion and ensures consistent service delivery across markets.